Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics' stock faces scrutiny over regulatory concerns and patient safety following gene therapy deaths, while analysts remain optimistic about Elevidys' long-term potential.
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. is a healthcare company focused on gene therapy for rare diseases.
Sarepta Therapeutics, Inc. uses the ticker $SRPT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Sarepta Therapeutics, Inc. (SRPT) creators near a 52-week low at [--].
- Sarepta Therapeutics, Inc. (SRPT) market dominance near a 52-week low at [-------].
- Sarepta Therapeutics, Inc. (SRPT) sentiment is up 33.33% from the previous week.
- Sarepta Therapeutics, Inc. (SRPT) posts created is up 62.66% from the previous month.
Price: $18.10
Price 24-Hour Time-Series Raw Data
The stock price has experienced a significant downturn due to missed Q4 Elevidys sales targets and regulatory headwinds. However, recent social media sentiment indicates expectations of a recovery fueled by anticipated data releases and positive sales reports, such as Elevidys being listed on Japan's NHI drug price list.
24-Hour: 1.34% 7-Day: -2% 30-Day: -13.92%
1-Year High: $108.40 on 2025-02-20
1-Year Low: $11.90 on 2025-07-25
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Sarepta Therapeutics, Inc. (SRPT) is currently AltRank #1,151 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] +389
[--] Month: [-----] +1,006
[--] Months: [-----] +1,093
[--] Year: [-----] +1,084
1-Year High: [-----] on 2025-03-16
1-Year Low: [--] on 2025-03-19
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +8
[--] Months: [--] +7
[--] Year: [--] [---]
1-Year High: [--] on 2025-10-02
1-Year Low: [--] on 2025-03-09
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] -40%
[--] Month: [---------] +65%
[--] Months: [----------] -51%
[--] Year: [----------] +65%
1-Year High: [---------] on 2025-07-18
1-Year Low: [-----] on 2025-03-09
Engagements by network (24h): YouTube: [--] News: [--] X: [------] Reddit: [--] TikTok: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -17%
[--] Month: [-----] +54%
[--] Months: [------] -61%
[--] Year: [------] +326%
1-Year High: [-----] on 2025-07-18
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): YouTube: [--] News: [--] X: [---] Reddit: [--] TikTok: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Sarepta Therapeutics, Inc. (SRPT) in the last [--] hours which is down 32% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -26%
[--] Month: [---] +50%
[--] Months: [-----] -74%
[--] Year: [------] +692%
1-Year High: [-----] on 2025-07-17
1-Year Low: [--] on 2025-02-24
The most influential creators that mention Sarepta Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @commonsenseplay | [--] | [------] | [--] | [-----] |
| @yachmod | [--] | [-----] | [--] | [---] |
| @marketmason1 | [--] | [-----] | [--] | [---] |
| @TheShortSqueezy | [--] | [-----] | [--] | [---] |
| @BRSreality | [--] | [-------] | [--] | [---] |
| @C_3C_3 | [--] | [----------] | [--] | [---] |
| @OptionsAlertsAi | [--] | [---] | [--] | [---] |
| @TequilaVernetti | [--] | [--] | [--] | [---] |
| @SMALLCAPSAXIS | [--] | [-----] | [--] | [---] |
| @n_hatami | [--] | [---] | [--] | [---] |
Sentiment: 72%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 72%
Daily Average: 71%
[--] Week: 100% +25%
[--] Month: 68% +4%
[--] Months: 68% -12%
[--] Year: 68% -3%
1-Year High: 97% on 2025-07-04
1-Year Low: 34% on 2025-05-07
Most Supportive Themes:
- Elevidys Potential: (55%) Analysts are optimistic about Sarepta Therapeutics' potential for gene therapy, particularly Elevidys, citing potential upside and long-term value.
Most Critical Themes:
- Regulatory Concerns: (10%) Concerns about regulatory issues and market volatility following two patient deaths linked to Sarepta's gene therapy.
Social Dominance: 0.00901%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00901%
Daily Average: 0.073%
[--] Week: 0.027% -0.04%
[--] Month: 0.017% -0.027%
[--] Months: 0.017% -0.105%
[--] Year: 0.017% -0.036%
1-Year High: 0.576% on 2025-07-18
1-Year Low: 0.014% on 2025-12-06
Market Dominance: 0.00214%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00214%
Daily Average: 0%
1-Year High: 0.371% on 2025-03-01
1-Year Low: 0.00212% on 2026-02-17
Market Cap: $1,901,887,444
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,901,887,444
Daily Average: $3,282,634,036
[--] Week: $1,902,935,316 +3%
[--] Month: $1,902,935,316 -14%
[--] Months: $1,902,935,316 -10%
[--] Year: $1,902,935,316 -84%
1-Year High: $10,519,247,034 on 2025-02-20
1-Year Low: $1,172,444,992 on 2025-07-25
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing